Inventor
SCHIFFMAN RHETT M
US32 patents
⚠️ This page may combine multiple inventors who share the name “SCHIFFMAN RHETT M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
16 patentsUS7851504B2Dec 14, 2010
Enhanced bimatoprost ophthalmic solution
ALLERGAN INC24 citations96
US9061065B2Jun 23, 2015
Intracameral sustained release therapeutic agent implants
ALLERGAN INC15 citations92
US8933120B2Jan 13, 2015
Enhanced bimatoprost ophthalmic solution
ALLERGAN INC13 citations92
US8586630B2Nov 19, 2013
Enhanced bimatoprost ophthalmic solution
ALLERGAN INC8 citations92
US7842714B2Nov 30, 2010
Ketorolac tromethamine compositions for treating ocular pain
ALLERGAN INC23 citations91
US10278919B2May 7, 2019
Intracameral sustained release therapeutic agent implants
ALLERGAN INC10 citations84
US9504696B2Nov 29, 2016
Intracameral sustained release therapeutic agent implants
ALLERGAN INC8 citations84
US9155716B2Oct 13, 2015
Enhanced bimatoprost ophthalmic solution
ALLERGAN INC4 citations84
US8772338B2Jul 8, 2014
Enhanced bimatoprost ophthalmic solution
ALLERGAN INC5 citations84
US9937188B2Apr 10, 2018
Non-irritating testosterone emulsions
ALLERGAN INC5 citations81
US7557082B2Jul 7, 2009
Treatment with cyclosporin A
ALLERGAN INC7 citations74
US9579328B2Feb 28, 2017
Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use
ALLERGAN INC2 citations73
US9248135B2Feb 2, 2016
Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use
ALLERGAN INC3 citations73
US9101550B2Aug 11, 2015
Compositions for enhancing nail growth
ALLERGAN INC2 citations53
US10780098B2Sep 22, 2020
Non-irritating testosterone emulsions
ALLERGAN INC0 citations49
US10610565B2Apr 7, 2020
Prevention and treatment of ocular side effects with a cyclosporin
ALLERGAN INC0 citations48
CHANG CHIN-MING
7 patentsUS8299118B2Oct 30, 2012
Enhanced bimatoprost ophthalmic solution
CHANG CHIN-MING27 citations96
US8338479B2Dec 25, 2012
Enhanced bimatoprost ophthalmic solution
CHANG CHIN-MING10 citations92
US8309605B2Nov 13, 2012
Enhanced bimatoprost ophthalmic solution
CHANG CHIN-MING20 citations92
US8278353B2Oct 2, 2012
Enhanced bimatoprost ophthalmic solution
CHANG CHIN-MING16 citations92
US9241918B2Jan 26, 2016
Enhanced bimatoprost ophthalmic solution
CHANG CHIN-MING5 citations84
US8524777B2Sep 3, 2013
Enhanced bimatoprost ophthalmic solution
CHANG CHIN-MING7 citations84
US8933127B2Jan 13, 2015
Enhanced bimatoprost ophthalmic solution
CHANG CHIN-MING3 citations62
SCHIFFMAN RHETT M
3 patentsFEINERMAN GREGG
2 patentsCELLA THERAPEUTICS LLC
2 patentsUS11147855B2Oct 19, 2021
Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour
CELLA THERAPEUTICS LLC3 citations70
US12128104B2Oct 29, 2024
Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-alpha (TNF-alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease inhibitor
CELLA THERAPEUTICS LLC1 citations59